Connection

Weijin Huang to Vero Cells

This is a "connection" page, showing publications Weijin Huang has written about Vero Cells.
Connection Strength

0.133
  1. Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19. Emerg Microbes Infect. 2021 Dec; 10(1):1574-1588.
    View in: PubMed
    Score: 0.018
  2. A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants. Nat Commun. 2021 08 17; 12(1):5000.
    View in: PubMed
    Score: 0.017
  3. Discovery and evolution of 12N-substituted aloperine derivatives as anti-SARS-CoV-2 agents through targeting late entry stage. Bioorg Chem. 2021 10; 115:105196.
    View in: PubMed
    Score: 0.017
  4. Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys. Nat Commun. 2020 11 13; 11(1):5752.
    View in: PubMed
    Score: 0.016
  5. Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science. 2020 09 18; 369(6510):1505-1509.
    View in: PubMed
    Score: 0.016
  6. A Thermostable mRNA Vaccine against COVID-19. Cell. 2020 09 03; 182(5):1271-1283.e16.
    View in: PubMed
    Score: 0.016
  7. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 2020 09 03; 182(5):1284-1294.e9.
    View in: PubMed
    Score: 0.016
  8. A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature. 2020 08; 584(7819):120-124.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.